A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects

Name: A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects
Published: 2019
License: Public Domain

AstraZeneca · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

chinese dyslipidemia japanese metabolic-disorders

metabolic disorders, non-alcoholic steatohepatitis, single-ascending-dose, first-in-human, chinese, japanese, dyslipidemia, type ii diabetes mellitus, non-alcoholic fatty liver disease, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects

Related documents